A 2023 Australian survey found that cannabis users frequently report dual medical-recreational motives rather than distinct categories. This cross-sectional analysis of 3,042 adults reveals that australian medical cannabis use patterns are more nuanced than regulatory frameworks suggest, with important implications for clinical practice and patient counseling.
What Federal Cannabis Rescheduling Means for Care
Cannabis Schedule III rescheduling marks a major shift in how cannabis is classified and understood at the federal level. This change begins to align policy with clinical reality, affecting research, documentation, and patient access. Cannabis Schedule III rescheduling does not solve every clinical challenge, but it opens the door to more structured and evidence-driven care.
Attitudes, beliefs and willingness to prescribe medical cannabis among public medical practitioners in Malaysia.
A nationwide survey of Malaysian physicians reveals measured acceptance of medical cannabis, with 65% supporting availability for certain conditions. The strongest support emerged for pain management applications, where 87% of doctors endorsed medical cannabis use and 74% would recommend it for cancer pain.
Canadian real-world evidence: observational 24-week outcomes for health care practitioner authorized cannabis.
A large Canadian observational study demonstrates medical cannabis real world effectiveness across chronic pain, anxiety, and sleep disorders over 24 weeks. This real-world evidence provides clinicians with practical outcome expectations for sustained cannabis therapy under physician supervision.
Medical Cannabis Use in Autism: Insights from an Israeli HMO on Patient Characteristics and Alignment with National Guidelines.
A large Israeli healthcare study examining medical cannabis prescribing patterns autism children found only 1.2% of autistic individuals received prescriptions, but concerning pediatric use patterns suggest need for stricter clinical oversight and guideline adherence.
Higher THC Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review.
A rapid review of 15 studies examining higher THC medicinal cannabis efficacy and safety found therapeutic benefit for chronic pain and PTSD, but confirmed increased risk of cognitive and psychiatric adverse effects. This evidence provides important clinical guidance for prescribing higher THC medicinal cannabis products in appropriate patient populations.
Medical marijuana for management of cancer pain: a narrative review.
A 2025 narrative review examines medical marijuana for cancer pain management across 20 recent studies, highlighting ongoing knowledge gaps despite expanding legal access. While the review consolidates current research trends, specific efficacy conclusions require full study analysis beyond this abstract.
Effects of prescribed medical cannabis and alcohol on real-world driving performance (CAN-TRACK): a study protocol for a two-phase trial.
Australian researchers have published a comprehensive medical cannabis driving safety study protocol designed to assess real-world driving performance in patients using therapeutic THC. This two-phase trial could provide critical evidence to inform driving safety policies for the growing medical cannabis patient population.
Medical Cannabis for the Treatment of Peripheral Neuropathy due to Diabetes: A Systematic Review.
New systematic review evidence shows cannabis for diabetic peripheral neuropathy can provide significant pain relief, with THC-containing products demonstrating the strongest efficacy. This research offers clinicians evidence-based guidance for considering cannabinoid interventions in treatment-resistant diabetic nerve pain cases.
What Does President Trump’s Executive Order Rescheduling Medical Cannabis Do … – YouTube
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyFederal RegulationMedical CannabisClinical PracticeHealthcare Access Why This MattersFederal rescheduling of cannabis would fundamentally alter...